Treatment Effect According to Timing of Administration of DWP14012 40 mg

Status:
Not yet recruiting

Trial end date:
2021-12-30

Target enrollment:

Participant gender:

The primary objective of this study is to establish noninferiority of efficacy of DWP14012 (40 mg once daily) based on Timing of Administration.

N/A

Daewoong Pharmaceutical Co. LTD.

Hanyang University